PubRank

Cornelia Mauch

Author PubWeight™ 87.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial. Lancet 2012 13.89
2 Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med 2014 10.38
3 Stromal expression of MMP-13 is required for melanoma invasion and metastasis. J Invest Dermatol 2009 1.75
4 Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma. Cancer 2010 1.66
5 Merkel cell polyomavirus DNA in persons without merkel cell carcinoma. Emerg Infect Dis 2009 1.45
6 Podoplanin expression in cutaneous head and neck squamous cell carcinoma--prognostic value and clinicopathologic implications. J Surg Oncol 2012 1.44
7 [Patients' view of melanoma follow-up]. J Dtsch Dermatol Ges 2004 1.43
8 Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol 2006 1.43
9 Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma. J Clin Oncol 2006 1.41
10 Eradication of melanomas by targeted elimination of a minor subset of tumor cells. Proc Natl Acad Sci U S A 2011 1.31
11 Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group. J Clin Oncol 2005 1.27
12 Mechanical tension and integrin alpha 2 beta 1 regulate fibroblast functions. J Investig Dermatol Symp Proc 2006 1.26
13 Transmembrane collagen XVII, an epithelial adhesion protein, is shed from the cell surface by ADAMs. EMBO J 2002 1.22
14 Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases. Cancer Med 2013 1.19
15 Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells. Oncotarget 2012 1.11
16 Blood-based gene expression signatures in non-small cell lung cancer. Clin Cancer Res 2011 1.09
17 Gene expression profiling reveals cross-talk between melanoma and fibroblasts: implications for host-tumor interactions in metastasis. Cancer Res 2005 1.06
18 Loss of serum response factor in keratinocytes results in hyperproliferative skin disease in mice. J Clin Invest 2009 1.03
19 Ubiquitin C-terminal hydrolase-L1 potentiates cancer chemosensitivity by stabilizing NOXA. Cell Rep 2013 0.99
20 The proteasome inhibitor bortezomib sensitizes melanoma cells toward adoptive CTL attack. Cancer Res 2010 0.99
21 Expression of membrane type 1 matrix metalloproteinase in papillomavirus-positive cells: role of the human papillomavirus (HPV) 16 and HPV8 E7 gene products. J Gen Virol 2005 0.97
22 Role of ADAM-9 disintegrin-cysteine-rich domains in human keratinocyte migration. J Biol Chem 2007 0.96
23 Ocular diseases in metastatic cutaneous melanoma: review of 108 consecutive patients in two German tertiary centers. Graefes Arch Clin Exp Ophthalmol 2014 0.95
24 Dissociation of the complex between CD151 and laminin-binding integrins permits migration of epithelial cells. Exp Cell Res 2006 0.95
25 Mast cells play a protumorigenic role in primary cutaneous lymphoma. Blood 2012 0.93
26 c-Fos-dependent induction of the small ras-related GTPase Rab11a in skin carcinogenesis. Am J Pathol 2005 0.93
27 Transcriptional profiling identifies an interferon-associated host immune response in invasive squamous cell carcinoma of the skin. Int J Cancer 2008 0.91
28 The invasive potential of human melanoma cell lines correlates with their ability to alter fibroblast gene expression in vitro and the stromal microenvironment in vivo. Int J Cancer 2009 0.91
29 Identification and discrimination of extracellularly active cathepsins B and L in high-invasive melanoma cells. Anal Biochem 2006 0.91
30 Delayed wound healing and epidermal hyperproliferation in mice lacking JunB in the skin. J Invest Dermatol 2006 0.90
31 Adam-9 expression and regulation in human skin melanoma and melanoma cell lines. Int J Cancer 2005 0.90
32 Expression of matrix metalloproteinase (MMP)-2, MMP-9, MMP-13, and MT1-MMP in skin tumors of human papillomavirus type 8 transgenic mice. Exp Dermatol 2006 0.90
33 Loss of epidermal Evi/Wls results in a phenotype resembling psoriasiform dermatitis. J Exp Med 2013 0.89
34 Gene expression profiling of lichen planus reflects CXCL9+-mediated inflammation and distinguishes this disease from atopic dermatitis and psoriasis. J Invest Dermatol 2007 0.89
35 High invasive melanoma cells induce matrix metalloproteinase-1 synthesis in fibroblasts by interleukin-1alpha and basic fibroblast growth factor-mediated mechanisms. J Invest Dermatol 2005 0.88
36 Expression and function of the kallikrein-related peptidase 6 in the human melanoma microenvironment. J Invest Dermatol 2011 0.87
37 Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography. J Pathol 2002 0.87
38 Short German guidelines: Merkel cell carcinoma. J Dtsch Dermatol Ges 2008 0.87
39 Induction of durable responses by oral etoposide monochemotherapy in patients with metastatic Merkel cell carcinoma. Eur J Dermatol 2012 0.86
40 MT1-MMP cleaves Dll1 to negatively regulate Notch signalling to maintain normal B-cell development. EMBO J 2011 0.86
41 Identification and clinical relevance of PD-L1 expression in primary mucosal malignant melanoma of the head and neck. Melanoma Res 2015 0.86
42 Defective laminin 5 processing in cylindroma cells. Am J Pathol 2002 0.85
43 Contact of high-invasive, but not low-invasive, melanoma cells to native collagen I induces the release of mature cathepsin B. Int J Cancer 2006 0.85
44 Role of postoperative radiotherapy in the management of Merkel cell carcinoma. Am J Clin Oncol 2002 0.85
45 Upregulation of lipocalin-2 in human papillomavirus-positive keratinocytes and cutaneous squamous cell carcinomas. J Gen Virol 2010 0.84
46 Complete remission of Merkel cell carcinoma of the scalp with local and regional metastases after topical treatment with dinitrochlorbenzol. J Am Acad Dermatol 2004 0.84
47 Migration of epithelial cells on laminins: RhoA antagonizes directionally persistent migration. Eur J Cell Biol 2010 0.84
48 Melanoma cell-derived vascular endothelial growth factor induces endothelial tubulogenesis within fibrin gels by a metalloproteinase-mediated mechanism. Eur J Cell Biol 2006 0.84
49 Role of the snake venom toxin jararhagin in proinflammatory pathogenesis: in vitro and in vivo gene expression analysis of the effects of the toxin. Arch Biochem Biophys 2005 0.83
50 Enhanced deposition of cartilage oligomeric matrix protein is a common feature in fibrotic skin pathologies. Matrix Biol 2013 0.83
51 Expression of matrilin-2 in human skin. J Invest Dermatol 2002 0.83
52 The disintegrin-like and cysteine-rich domains of ADAM-9 mediate interactions between melanoma cells and fibroblasts. J Biol Chem 2010 0.82
53 Human papillomavirus type 8 E6 oncoprotein inhibits transcription of the PDZ protein syntenin-2. J Virol 2012 0.81
54 A decreased ratio between serum levels of the antagonistic angiopoietins 1 and 2 indicates tumour progression of malignant melanoma. Arch Dermatol Res 2012 0.81
55 Monocyte/macrophage MMP-14 modulates cell infiltration and T-cell attraction in contact dermatitis but not in murine wound healing. Am J Pathol 2013 0.80
56 Sodium-dependent vitamin C transporter isoforms in skin: Distribution, kinetics, and effect of UVB-induced oxidative stress. Free Radic Biol Med 2007 0.80
57 An attempt at a molecular prediction of metastasis in patients with primary cutaneous melanoma. PLoS One 2012 0.79
58 A novel aspartic proteinase-like gene expressed in stratified epithelia and squamous cell carcinoma of the skin. Am J Pathol 2006 0.79
59 Proteomic anatomy of human skin. J Proteomics 2013 0.79
60 [Tumor-stroma interactions: their role in the control of tumor cell invasion and metastasis]. J Dtsch Dermatol Ges 2006 0.79
61 Role of ADAM-15 in wound healing and melanoma development. Exp Dermatol 2012 0.79
62 Health-related quality of life, fatigue, and depression under low-dose IFN-α therapy in melanoma patients. J Immunother 2014 0.78
63 Loss of epidermal MMP-14 expression interferes with angiogenesis but not with re-epithelialization. Eur J Cell Biol 2012 0.78
64 The reprolysin jararhagin, a snake venom metalloproteinase, functions as a fibrillar collagen agonist involved in fibroblast cell adhesion and signaling. J Biol Chem 2002 0.78
65 Host response to human breast Invasive Ductal Carcinoma (IDC) as observed by changes in the stromal proteome. J Proteome Res 2014 0.77
66 Stromal fibroblast-specific expression of ADAM-9 modulates proliferation and apoptosis in melanoma cells in vitro and in vivo. J Invest Dermatol 2012 0.77
67 Extensive amplification of human regulatory T cells alters their functional capacities and targets them to the periphery. Rejuvenation Res 2008 0.77
68 Human scalp dermal papilla and fibrous sheath cells have a different expression profile of matrix metalloproteinases in vitro when compared to scalp dermal fibroblasts. Arch Dermatol Res 2005 0.77
69 Invasion of melanoma cells into dermal connective tissue in vitro: evidence for an important role of cysteine proteases. Int J Cancer 2003 0.76
70 Lack of integrin β5 in Merkel cell carcinomas and derived cell lines is frequently associated with Merkel cell polyomavirus positivity. J Dermatol Sci 2012 0.75
71 [Metronomic chemotherapy. Should we change our thinking in the treatment of advanced tumors?]. J Dtsch Dermatol Ges 2005 0.75
72 PECAM1(+)/Sca1(+)/CD38(+) vascular cells transform into myofibroblast-like cells in skin wound repair. PLoS One 2013 0.75
73 Linear livid papules on the leg in a 4-year-old child. Pediatr Dermatol 2008 0.75
74 TGF-β1-dependent induction and nuclear translocation of FHL2 promotes keratin expression in pilomatricoma. Virchows Arch 2014 0.75
75 Successful treatment of a folliculotropic mycosis fungoides with bexarotene and PUVA. Eur J Dermatol 2012 0.75